- Report
- October 2024
- 198 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 279 Pages
Global
From €5201EUR$5,450USD£4,358GBP
- Report
- November 2024
- 180 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2025
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- March 2025
- 93 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- June 2021
- 165 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- March 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Book
- February 2024
North America
Lung cancer surgery is a medical procedure used to treat lung cancer. It is often used in combination with other treatments such as chemotherapy and radiation therapy. The goal of surgery is to remove the cancerous tissue and any surrounding tissue that may be affected. Surgery is usually the first line of treatment for early-stage lung cancer, and may be used in more advanced stages as well.
The lung cancer surgery market is a subset of the larger lung cancer drugs market. It is composed of medical devices, surgical instruments, and other products used in the surgical treatment of lung cancer. Companies in this market include medical device manufacturers, surgical instrument suppliers, and other companies that provide products and services related to lung cancer surgery.
Some companies in the lung cancer surgery market include Medtronic, Stryker, Johnson & Johnson, Becton Dickinson, and Smith & Nephew. Show Less Read more